Susanna Naggie, MD Discussed HBV and HCV Coverage at AASLD

Volume 3, Issue 8.

Susanna Naggie, MD, Professor, Assistant Professor of Medicine, Department of Medicine – Infectious Diseases at Duke University School of Medince discusses the development of new therapies for treating hepatitis C infection, and news about hepatitis B from the 64th meeting of the American Association for the Study of Liver Disease, as well as case-study scenarios for the clinical practice.

Cure of Hepatitis B: Is it Achievable?

Volume 3, Issue 6.

Dr. Fabien Zoulim, MD, PhD, Professor, head of INSERM Viral Hepatitis Laboratory at the Medical School of Lyon, Lyon 1 University, Hepatology Department, Hospices Civils de Lyon in Lyon, France discusses the topic of HBV cure, in the form of case-study scenarios for the clinical practice.

The Role of Prediction Models: Best practices in Identifying Cirrhosis and HCC in Patients Infected with HBV

Volume 3, Issue 4.

Dr. Anna Suk-Fong Lok, MD, FRCP, Professor in the Department of Internal Medicine and Director of Clinical Hepatology in the Division of Gastroenterology at the University of Michigan Health System discusses predictive models for cirrhosis in the form of case-study scenarios for the clinical practice.

European Association for the Study of the Liver HCV Update

Volume 3, Issue 2.

Dr. Mark Sulkowski from The Johns Hopkins University School of Medicine discusses advancements in hepatitis C therapy presented at EASL, as well as case-study scenarios for the clinical practice.

HCV/HIV Coinfection

Volume 2, Issue 8.

Dr. Mark Sulkowski, Professor and Medical Director of the Viral Hepatitis Center at Johns Hopkins University School of Medicine will describe the epidemiology of HCV infection in HIV-infected persons including the role of sexual transmission of HCV.

Occult Hepatitis B Virus Infection

Volume 2, Issue 6.

Dr. Kennenth Sherman, Gould Professor of Medicine and Director of the Division of Digestive Disease at the University of Cincinnati College of Medicine will diferentiate how occult HBV differs from classical HBV infections.

Dr. Tram T. Tran will cover issues related to Hepatitis B and Pregnancy

Volume 2, Issue 4-Hepatitis B and Pregnancy.

Dr. Tram T Tran, Medical Director of the Liver Transplantation Program at the Liver Disease and Transplant Center at Cedars-Sinai Medical Center and Associate Professor of Medicine at the David Geffen School of Medicine at UCLA will present patient case scenarios which: review current screening recommendations for hepatitis B, Assess strategies to reduce mother-to-child transmission (MTCT) of hepatitis B, and review recommendations and vaccination of hepatitis B infected mothers.